( MENAFN - GlobeNewsWire - Nasdaq) NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C.
, a nationally recognized shareholder rights law firm, is investigating potential claims against CVS health Corporation (NYSE: CVS) on behalf of long-term stockholders following a class action complaint that was filed against CVS on July 12, 2024 with a Class Period from May 3, 2023 to April 30, 2024. Our investigation concerns whether the board of directors of CVS have breached their fiduciary duties to the company. CVS is a healthcare company that operates through three primary segments: health care Benefits, Health Services, and Pharmacy & Consumer Wellness.
The Health Care Benefits segment purportedly offers“a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, [prescription drug plans] and Medicaid health care management services.” The Health Care Benefits segment's revenues consist almost entirely of insurance premiums paid by customers. The pricing and other terms of the Company's private health insurance plans are typically determined in advance of a plan's policy period, which is typically one year.
CVS determines premiums for these plans based on internal forecasts that consider historical data and the profitability of which are dependent on the Company's ab.